Why GLP-1s could become the "everything drug"

axios.com/2025/07/28/wegovy-new-uses-cost-safety

The biggest buzz around GLP-1 drugs these days has nothing to do with weight loss. And that might lead to some problems for patients and insurers.
The big picture: Blockbuster treatments like Ozempic have been found to lower the risk of everything from Alzheimer's and addiction, to sleep…

This story appeared on axios.com, 2025-07-28 09:30:00.
The Entire Business World on a Single Page. Free to Use →